PUBLISHER: IMARC | PRODUCT CODE: 1467754
PUBLISHER: IMARC | PRODUCT CODE: 1467754
The global vaginal slings market size reached US$ 1.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.3 Billion by 2032, exhibiting a growth rate (CAGR) of 6.1% during 2024-2032.
Vaginal slings are surgeries treating stress urinary incontinence among women, which includes urine leakage caused by increased pressure in the abdomen. They help close the urethra and bladder neck with a piece of tissue or artificial mesh underneath the urethra. They offer several advantages to patients, such as a small vaginal incision, faster post-operative recovery time, and no requirement for abdominal incision and hospital stay. As a result, they are carried out in hospitals, clinics, and ambulatory surgical centers across the globe.
Due to pregnancy, childbirth, and menopause, which may affect the urinary tract and surrounding muscles, there is a rise in the prevalence of stress urinary incontinence in women. This, along with the growing female geriatric population around the world, represents one of the key factors driving the market. Moreover, the rising awareness among the masses about the benefits of vaginal slings compared to conventional surgeries is contributing to the growth of the market. In addition, there is an increase in the number of hysterectomy cases due to uterine fibroids, which cause pain, bleeding, or other problems. This, coupled with the burgeoning healthcare industry, is strengthening the growth of the market. Besides this, governments of several countries are undertaking initiatives to improve healthcare infrastructure across the globe. Furthermore, the increasing number of gynecological and urological centers to cater to the demand for vaginal sling procedures is positively influencing the market. Apart from this, key market players are extensively investing in research and development (R&D) activities to introduce technologically advanced vaginal sling products, which is expected to propel the growth of the market in the coming years.
IMARC Group provides an analysis of the key trends in each sub-segment of the global vaginal slings market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, product type, type of urinary incontinence, and end user.
Conventional Vaginal Slings
Advanced Vaginal Slings
Transobturator Slings
Tension-free Vaginal Tape Sling
Others
Stress Urinary Incontinence
Urge Urinary Incontinence
Mixed Urinary Incontinence
Hospitals
Ambulatory Surgery Centers
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being A.M.I. GmbH, B. Braun Melsungen AG, Betatech Medical, Boston Scientific Corporation, Caldera Medical, Coloplast A/S, Cousin Biotech, Medtronic plc, Neomedic International and Promedon GmbH.